Functional experiments have shown that overexpression of miR-506 could inhibit the migration and invasion of glioma cells and reduce the protein expression levels of MMP2, cyclin D1 and Bcl-2 [42]. This evidence concerns the gene BCL2 and central nervous system cancer.